Blog
Discover our latest articles and blogs
GLP-2 Peptide Research: Mechanism, Evidence and Handling
GLP-2 peptide research explained: receptor signaling, intestinal and absorption findings, teduglutide trial data, safety signals and Australian context.
Peptide Residual Solvents: Testing, Limits and COA Checks
What residual solvents are in synthetic peptides, why HPLC purity does not show them, how headspace GC and Karl Fischer work, and what to read on a COA.
Semax vs Selank: Differences, Evidence and Australian Rules
Semax vs Selank compared: structure, research focus, evidence quality, safety questions and what Australian TGA rules mean for researchers sourcing either peptide.
Follistatin-344 Research: Mechanism, Evidence and Australian Rules
What published Follistatin-344 research shows, how it differs from gene-transfer trials, how to verify a research vial, and what TGA rules apply in Australia.
In Vitro Peptide Concentrations: How to Set and Calculate Them
How to choose a starting in vitro peptide concentration, build a dose-response range, calculate dilutions from stock and report results, with a worked example.
TLR Peptides in Research: Targets, Mechanisms and Limits
How TLR peptides are used in research: agonists, inhibitors and decoys, target domains, lab models, evidence limits and Australian compliance for 2026.
Peptide Import GST in Australia: What Applies in 2026
How GST, duty and import charges apply to peptides entering Australia, and why TGA rules and the Personal Importation Scheme matter more than the tax.
Peptide Precipitation Fix: Diagnose, Recover or Discard
Cloudy or precipitated peptide? Learn which causes are reversible, how to test a vial step by step, and when to discard it. Covers ether precipitation too.
Skin Signal Peptides: How They Work and What the Evidence Shows
Skin signal peptides explained: how they act on fibroblasts, what human trials show on wrinkles and collagen, and how Australian rules treat them.